Russell Frank Company’s Emergent Biosolutions EBS Stock Holding History

Russell Frank Company’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$16.7M	Buy	458,398 +164,937	+56%	+$5.83M	0.03%	667
2015 Q4	$11.8M	Buy	293,461 +110,719	+61%	+$3.86M	0.02%	791
2015 Q3	$5.21M	Buy	182,742 +19,049	+12%	+$628K	0.01%	1249
2015 Q2	$5.39M	Buy	163,693 +23,832	+17%	+$739K	0.01%	1371
2015 Q1	$4.02M	Sell	139,861 -47,744	-25%	-$1.37M	0.01%	1371
2014 Q4	$5.09M	Sell	187,605 -11,879	-6%	-$283K	0.01%	1283
2014 Q3	$4.25M	Sell	199,484 -53,370	-21%	-$1.22M	0.01%	1381
2014 Q2	$5.68M	Buy	252,854 +14,156	+6%	+$330K	0.01%	1241
2014 Q1	$6.03M	Buy	238,698 +143,939	+152%	+$3.64M	0.01%	1181
2013 Q4	$2.21M	Sell	94,759 -70,807	-43%	-$1.48M	﹤0.01%	1664
2013 Q3	$3.15M	Sell	165,566 -25,394	-13%	-$453K	0.01%	1606
2013 Q2	$2.75M	Buy	+190,960	New	+$2.77M	0.01%	1585

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Russell Frank Company's EBS Position: Q1 2016 in Review

Russell Frank Company increased its Emergent Biosolutions (EBS) stake by 56% in Q1 2016, buying an estimated $5.83M and bringing the position to 458,398 shares worth $16.7M. The position accounts for 0.03% of the portfolio, ranked #667.

Russell Frank Company first reported a position in EBS in Q2 2013 and has held it in 12 quarters since. 214 funds tracked by Wall St. Rank hold EBS as of Q1 2016.

Russell Frank Company held 458,398 shares of Emergent Biosolutions worth $16.7M as of Q1 2016.
Russell Frank Company bought 164,937 Emergent Biosolutions shares in Q1 2016, an estimated $5.83M.
Emergent Biosolutions made up 0.03% of Russell Frank Company's portfolio in Q1 2016, its #667 holding.
Russell Frank Company first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 12 quarters since.
214 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.